Regeneron Pharmaceuticals Inc
Rilonacept Injection, Dupilumab Injection, Aflibercept Injection, Sarilumab Injection, Emiplimab-Rwlc Injection, Alirocumab Injection
Rilonacept Injection, Dupilumab Injection, Aflibercept Injection, Sarilumab Injection, Emiplimab-Rwlc Injection, Alirocumab Injection
Regeneron is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for over 30 years by physician-scientists, its unique ability to repeatedly and consistently translate science into medicine has led to eight FDA-approved treatments and numerous product candidates in development, all of which were homegrown in their laboratories. Its medicines and pipeline are designed to help patients with eye disease, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, infectious diseases, pain and rare diseases.
We have 7663 contacts in our database, out of which 12% are decision makers. The distribution of leads are as follows:
In January, 2020 regeneron.com's total website visitor was 183166, increased by 30% from previous month. Some key metrics are Average time spent on site is 1 minutes, Bounce Rate is 69% and average page per visit is 1 respectively.
We Verified regeneron.com server for email deliverability.
Adobe is a global name in software industry. But software industry has too many participants that...
T-Mobile reached a definitive agreement to acquire the Sprint-branded wireless operating assets o...
Being an American multinational company Cognizant has access to a huge section of the IT industry...
SVB Financial Group to acquire Boston Private, a leading provider of wealth management, trust and...
Amazon.com is a worldwide name in the Internet and E-Commerce industry. Amazon may be termed as t...
© Copyright 2014-2021 by GetCompanyInfo.com. All Rights Reserved.
